chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the shot in my left arm on May 11th 2017 with my due date estimated to be August 1st 2017. My son was born weighing 7 pounds. I never felt sick my whole pregnancy and was very healthy. After I received the vaccine I immediately had a horrible pain in my arm and it felt like it was in my bone. It hurt to kiddy my arm and two days later became very sick. I was very dizzy to the point I could barely walk or drive. I had a fever and just did not feel good for about a week. The dizzy spell continued well after I had my child and the pain in my arm never went away it was difficult to use my arm at all and to hold my baby with my left arm was impossible. It left a mark where the vaccine was given and to this day it hurts and still have the mark. I was not given informed consent or was I informed of the side effects or ingredients of the vaccine.
HPV #1 (GARDASIL) on 3-15-13. Seen in office 4-11-13 with new onset daily headache approximately 2 weeks after HPV. Bifrontal - sharp stab lateral to (R) orbit and in (R) eye - usually triggered by reading. Normal exam by ophthalmologist.
About 2 hours post vaccine, at about 4:30PM, I started having stomach pain, I started with diarrhea, I threw up a little bit and I had nausea. I was like that for a week. I went to work the next day, but my stomach really hurt, and I came back home. I went to work the rest of that week, but I did not feel like it. The GI problems lasted for a week, with diarrhea and nausea. I took gas relief medication. I took Pepto Bismal.  I went back to clinic and asked someone there about the symptoms I was having, and they told me it was part of the symptoms of the side effects of the Pfizer vaccine.
Upon arising at 7AM I had tunnel vision. Just a little headache that morning. By 1:30pm I was chilling and could not get warm. Fever reached 101 degrees.  I took 2 Tylenol every 4 hours.  While I had a fever, I could not seem to drink enough water. I consumed about 90 ounces of water from 2pm til 9pm. The fever and chills became less prevalent by 9pm. Continued the Tylenol through 7AM the morning of 1/12/21. My chills were gone and I had no fever by then.
soreness on her arm; visual problems; moderate pain behind her left eye and forehead; High blood pressure; moderate pain behind her left eye and forehead; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (soreness on her arm), VISUAL IMPAIRMENT (visual problems), EYE PAIN (moderate pain behind her left eye and forehead), HYPERTENSION (High blood pressure) and HEADACHE (moderate pain behind her left eye and forehead) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040a21a) for COVID-19 vaccination.     Concomitant products included THYROID, HYDROCODONE, APIXABAN (ELIQUIS), METOPROLOL and LORAZEPAM (ATIVAN) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VISUAL IMPAIRMENT (visual problems), EYE PAIN (moderate pain behind her left eye and forehead), HYPERTENSION (High blood pressure) and HEADACHE (moderate pain behind her left eye and forehead). On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness on her arm). At the time of the report, PAIN IN EXTREMITY (soreness on her arm), VISUAL IMPAIRMENT (visual problems), EYE PAIN (moderate pain behind her left eye and forehead) and HEADACHE (moderate pain behind her left eye and forehead) had resolved and HYPERTENSION (High blood pressure) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: abnormal (High) 132-77, 140-82 and 152. On an unknown date, Heart rate: 57 High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided
Inappropriate route of vaccination; caught COVID several months later; caught COVID several months later/Suspected COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) subcutaneous for covid-19 immunisation; BNT162b2 (BNT162B2), in Jan2021 as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown), all subcutaneous for covid-19 immunisation. The patient's relevant medical history included: "metastatic breast cancer" (unspecified if ongoing), notes: Consumer has metastatic breast cancer which has spread to her bones and liver; "Consumer has metastatic breast cancer which has spread to her bones" (unspecified if ongoing); "Consumer has metastatic breast cancer which has spread to her liver" (unspecified if ongoing). The patient took concomitant medications. Reporter did not remember but lots of treatments for cancer. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "recovered", described as "caught COVID several months later"; SUSPECTED COVID-19 (medically significant), outcome "recovered", described as "caught COVID several months later/Suspected COVID-19"; INCORRECT ROUTE OF PRODUCT ADMINISTRATION (non-serious), outcome "unknown", described as "Inappropriate route of vaccination". Clinical course: Consumer had three Pfizer COVID vaccines and caught COVID several months later. She only had it for five days and felt she could have been much worse, had she not had the vaccines. She felt very protected. reporter consider event not caused by suspect product's.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the event (DRUG INEFFECTIVE,SUSPECTED COVID-19,  and BNT162B2 and BNT162B2, BNT162B2 OMI BA.4-5.
I had pain in my arm and a week later I got a really large, red rash around the vaccination site. It was hard to the touch and swollen. It went away within 48 hours. I used a cortisone cream on it to reduce itchiness.
quite a lot of shoulder pain after the 1st Moderna Shot; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (quite a lot of shoulder pain after the 1st Moderna Shot) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041821A) for COVID-19 vaccination.     Concurrent medical conditions included Liver disorder. Concomitant products included PREDNISONE for an unknown indication.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (quite a lot of shoulder pain after the 1st Moderna Shot). At the time of the report, ARTHRALGIA (quite a lot of shoulder pain after the 1st Moderna Shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication also included medications for Liver problem. Treatment information was not provided.
Erythema and pruritis to left shoulder (injection site) and abdomen noted 6.5 hours post-vaccination.  Presented to clinic the following night with urticaria of the abdomen and BL arms.  Patient was given 50mg of Benadryl in clinic and Zyrtec 10mg to take BID x 5 days beginning 05/06/2014.
Information has been received from a registered nurse concerning a 65 year old female patient with no drug reactions or allergies, who on 06-JUL-2009 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot # 664092/01998Y) SQ. The nurse reported that in February 2011, the patient developed shingles. There were no Lab diagnosis/studies performed. It was reported that oral antivirals and an unspecified ointment were given as treatment for the adverse event. The patient sought unspecified medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.
No additional AE; LPN calling to report administration of expired lot of VARIVAX. Per caller, lot had short-dated expiration from 6/28/2023 to 10/12/2022 due to past temperature excursion; vaccine was administered on 10/25/2022. No additional AEs, no PQCs.; LPN calling to report administration of expired lot of VARIVAX. Per caller, lot had short-dated expiration from 6/28/2023 to 10/12/2022 due to past temperature excursion; vaccine was administered on 10/25/2022. No additional AEs, no PQCs.; This spontaneous report was received from licensed practical nurse (LPN) and refers to an 18-month-old male patient. Information regarding the patient's medical history, concurrent conditions, concomitant therapies, and past drug allergies or drug reactions were not provided.  On an unspecified date, the varicella virus vaccine live (oka/merck) (VARIVAX) lot# U027326 experienced an unreported temperature excursion and due to this the expiration date was short-dated expiration from 28-JUN-2022 to 12-OCT-2022 (product storage error). However on 25-OCT-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, at a dose of 0.5 milliliters (ml) once administered for prophylaxis (lot #U027326 confirmed to be valid, expiration date reported as 12-OCT-2022, but upon internal validation the expiration date was assessed as 02-SEP-2023, conflicting information) (expired product administered and product storage error) (strength, and route of administration were not provided). No additional adverse event (AEs).
tenderness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (tenderness at the injection site) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Arthritis (Taking medication for arthritis).    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2011, the patient experienced INJECTION SITE PAIN (tenderness at the injection site). On 11-Mar-2021, INJECTION SITE PAIN (tenderness at the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
The day after Pt received shots she started with redness & swelling toward back of arm.  Treated with KEFLEX 50mg/kg/day divided TID and BENADRYL.  Within 2 days arm was much better per mom.
Patient administered moderna covid vaccine while temperature excursion was ongoing; Patient administered moderna covid vaccine while temperature excursion was ongoing; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing) in a 31-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Reporter confirmed that patients had been administered doses while the temperature excursion assessment has been ongoing.  No treatment medications were reported.
Cellulitis of right deltoid area, advised Tylenol/Motrin, Benadryl, and prescribed oral antibiotic.
Flu vacin I contract stop heart to relative, do 501C Merck STD.
Nosebleed - treated in ED. More nosebleeds over several weeks. Fever 99.6-100.6. Cervical lymphadenopathy.
Approx 48 hours after vaccine, pt felt fatigue causing excessive sleepiness, then HA, body aches developed. Low grade temp on day 3 with fatigue, dizziness. No S.T., no cough, no rash. No exposure to anyone will illness. Similar sx last yr 48 after flu shot.
My daughter had a very high pitched scream, which is still continuing now on 8/11 after receiving the vaccine on 8/8. The night after the vaccine she was very sleepy. The next day she cried inconsolably and was unable to take a nap for many hours. She also had very jerky movements and seemed to be in a great deal of pain. She still has a high pitched scream and is very fussy and has not returned to her normal self and continues to struggle to fall asleep whereas she easily fell asleep before being vaccinated. I hope that symptoms will resolve for her but feel this reaction wasn't normal and that parents should not be told symptoms will only last 48 hours when they can last much longer. I'm worried that the high pitched cry will be permanent my daughter never cried like this before the vaccine.
muscle weakness; arm soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 1, single and administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCULAR WEAKNESS (non-serious) with onset 2021, outcome "unknown", described as "muscle weakness"; PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "arm soreness".  Additional information: Patient received her first and second dose of the Pfizer Covid-19 vaccine adult dose in Mar2021 or Apr2021, and booster dose in 10Jan2022. Since that time she have been experiencing arm soreness and muscle weakness.   The lot number for bnt162b2 was not provided and will be requested during follow up.
PATIENT'S ARM WAS A PURPLE BRUISE THAT EXTENDED FROM HER SHOULDER TO HER ELBOW. SHE WAS IN PAIN AND HAD DIFFICULTY REMOVING AND DONNING HER JACKET.
Erythematous, raised lesions on her trunk 20 minutes after flu vaccination; not itchy; no other symptoms. Resolved with oral ZYRTEC/Ranitidine.
I had my vaccines and suddenly after two weeks approximately felt the tick symptoms disappear/After the covid vaccine my blood test came out no disease; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. Medical history included tick disease (serious tick disease for 3 years). The concomitant medications of the patient were not reported. The patient reported that after taking her second covid vaccine a strange event occurred. She has a serious tick disease for 3 years, and it reoccurs around the same months. She could feel it coming back. Then she had her vaccines and suddenly after two weeks approximately felt the tick symptoms disappeared. She had been having blood test every 3 months for 3 years to check the titers level. The disease was always present at different levels. After the covid vaccine her blood test came out no disease. The patient underwent lab tests and procedures which included blood test: blood test came out no disease on an unspecified date of 2021. The outcome of event was unknown.  Information about lot/batch number cannot be obtained. No further information expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Feb2022 at 15:00 as dose 1, single (Lot number: fm0698), in right arm and on 11Mar2022 at 15:00 as dose 2, single (Lot number: fm0698) at the age of 40 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: cinnamon, all spice, cloves" (unspecified if ongoing), notes: Known allergies: cinnamon, all spice, cloves; "Allergies" (unspecified if ongoing), notes: Allergies; "Asthma" (unspecified if ongoing); "Acid reflux" (unspecified if ongoing); "Thyroid nodules" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Lortab, reaction(s): "Allergy_Lortab"; Percocet, reaction(s): "Allergy_Percocet"; Biaxin, reaction(s): "Allergy_Biaxin"; Claritin, reaction(s): "Allergy_Claritin"; Allegra, reaction(s): "Allergy_Allegra"; Aspirin, reaction(s): "Allergy_Aspirin"; Azithromycin, reaction(s): "Allergy_Azithromycin". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: X-ray: Unknown results. Therapeutic measures were taken as a result of covid-19.  Clinical information: the patient wasn't taking any other medications/products within 2 weeks of starting COVID-19 treatment.  Antiviral details: paxlovid, started on 21Jul2022 and treatment stop date was 25Jul2022. The patient was put on mucinex, benzonatate, and had X-ray. Device Date: 04Aug2022.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information in the case, an association between the reported events Vaccination failure and Covid 19 and the suspect product bnt162b2 cannot be ruled out.
In 1991 w/in 2 days of vax pt devel a stiff neck;
This is a spontaneous report obtained from a non-contactable physician. This physician reported similar events for three patients. This is the first of three reports. A patient of unspecified age, gender and race received, on an unknown date, PREVNAR 13 at 0.5 ml single dose, for immunization. Medical history and concomitant medications were not provided. On an unspecified date, the patient experienced pain and swelling locally and it was hard for the patient rose hands over the head. Clinical outcome of the events was unknown at time of this report. No follow-up attempts possible. No further information expected. Sender's Comments: Linked Report(s): US-PFIZER INC-2016482854. Same reporter/drug/event different patients; US-PFIZER INC-2016483159. Same reporter/drug/event different patients.
This case was reported by a consumer via call center representative and described the occurrence of ear infection in a adult patient who received SHINGRIX for prophylaxis. In August 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced ear infection. The patient was treated with antibiotics nos and steroids nos (Steroids). On an unknown date, the outcome of the ear infection was unknown.  The reporter considered the ear infection to be unrelated to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient received SHINGRIX 3 months before the time of reporting. The patient was due for 2nd dose of SHINGRIX, but the patient was being treated with steroids and antibiotics to fight an ear infection. The patient wanted to know, would these medicines interfere with the SHINGRIX booster or should the patient wait until done with the antibiotics and steroids. The patient would prefer not to give personal information out. The call center representative arranged the call back to the patient with product specialists.
Complained of Chest Pain and palpitations starting at 10am 5/28. Radiation to neck. Been occurring for one month, but really uncomfortable on 5/28
Atrial flutter; This spontaneous case was reported by a consumer and describes the occurrence of ATRIAL FLUTTER (Atrial flutter) in a not specif patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ATRIAL FLUTTER (Atrial flutter). At the time of the report, ATRIAL FLUTTER (Atrial flutter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
One week after I got my 1st shot my left arm started to itch and feel swollen. The next day it was swollen the size of a baseball, red, sticking out an inch, itching and bumpy skin.
Woke up with a fever of 105 and very weak in the knees in the middle of the night. The fever went down with Motrin but remained in the 103-104 range for a few hours.